107 related articles for article (PubMed ID: 2749586)
1. Effects of calcium channel blockers on in vitro platelet function in whole blood using single platelet counting.
Walley TJ; Woods KL; Barnett DB
Thromb Haemost; 1989 Feb; 61(1):137-9. PubMed ID: 2749586
[TBL] [Abstract][Full Text] [Related]
2. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
3. Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
Glusa E; Bevan J; Heptinstall S
Thromb Res; 1989 Jul; 55(2):239-245. PubMed ID: 2528843
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.
Kiyomoto A; Sasaki Y; Odawara A; Morita T
Circ Res; 1983 Feb; 52(2 Pt 2):I115-9. PubMed ID: 6831645
[TBL] [Abstract][Full Text] [Related]
5. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet.
Rybak ME; Renzulli LA
Thromb Haemost; 1992 Jan; 67(1):131-6. PubMed ID: 1319614
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interaction of epinephrine and calcium ionophore in platelet aggregation.
Butt IF; Saeed SA; Waqar SN; Aslam M
J Ayub Med Coll Abbottabad; 2005; 17(2):1-5. PubMed ID: 16092638
[TBL] [Abstract][Full Text] [Related]
7. The antithrombogenic in vivo effects of calcium channel blockers in experimental thrombosis in mice.
Ortega MP; Sunkel C; Priego JG; Statkow PR
Thromb Haemost; 1987 Jun; 57(3):283-5. PubMed ID: 3660330
[TBL] [Abstract][Full Text] [Related]
8. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
Onoda JM; Sloane BF; Honn KV
Thromb Res; 1984 Jun; 34(5):367-78. PubMed ID: 6377570
[TBL] [Abstract][Full Text] [Related]
9. [Effect of calcium-channel blockers on human thrombocyte aggregation induced by alpha-adrenoreceptor agonists].
Ivleva AIa; Kobalava ZhD; Moiseev VS
Farmakol Toksikol; 1989; 52(2):77-80. PubMed ID: 2568273
[TBL] [Abstract][Full Text] [Related]
10. Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.
Ono H; Kimura M
Arzneimittelforschung; 1981; 31(7):1131-4. PubMed ID: 7196762
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C inhibitor, chelerythrine, potentiates the adrenaline-mediated aggregation of human platelets through calcium influx.
Shah BH; Shamim G; Khan S; Saeed SA
Biochem Mol Biol Int; 1996 May; 38(6):1135-41. PubMed ID: 8739035
[TBL] [Abstract][Full Text] [Related]
12. An investigation into the effects of nifedipine and nimodipine on platelet function and vascular prostacyclin synthesis.
Jeremy JY; Barradas MA; Mikhailidis DP; Dandona P
Drugs Exp Clin Res; 1985; 11(9):645-51. PubMed ID: 3939725
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
Timar J; Chopra H; Rong X; Hatfield JS; Fligiel SE; Onoda JM; Taylor JD; Honn KV
J Cancer Res Clin Oncol; 1992; 118(6):425-34. PubMed ID: 1377695
[TBL] [Abstract][Full Text] [Related]
14. Antiaggregatory activity of N-methyl- and N-isobutyl-1,2-diphenyl ethanolamines in rat platelets.
el Tahir KE; el-Naser MA; Ageel AM; el-Obeid HA; al-Rashood KA
Arch Int Pharmacodyn Ther; 1990; 307():162-71. PubMed ID: 2095711
[TBL] [Abstract][Full Text] [Related]
15. Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.
Johnson GJ; Leis LA; Francis GS
Thromb Res; 1990 Jul; 59(1):139-48. PubMed ID: 2399526
[TBL] [Abstract][Full Text] [Related]
16. Calcium entry blockers and human platelet aggregation.
Gotta AW; Capuano C; Hartung J; Sullivan CA
N Y State J Med; 1988 Mar; 88(3):132-3. PubMed ID: 3357613
[No Abstract] [Full Text] [Related]
17. Effects of calcium channel-blocking agents on platelet-osteogenic sarcoma interaction: platelet aggregation and electron microscopic findings.
Mehta P; Kimura A; Lawson D
J Orthop Res; 1990 Sep; 8(5):629-34. PubMed ID: 2388101
[TBL] [Abstract][Full Text] [Related]
18. Effects of some calcium antagonists on aggregation by adrenalin and serotonin and on alpha-adrenoceptor radioligand binding in human platelets.
Vinge E; Andersson TL; Larsson B
Acta Physiol Scand; 1988 Jul; 133(3):407-16. PubMed ID: 2906509
[TBL] [Abstract][Full Text] [Related]
19. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
[TBL] [Abstract][Full Text] [Related]
20. Verapamil inhibits proliferation, migration and protein kinase C activity in human retinal pigment epithelial cells.
Hoffman S; Gopalakrishna R; Gundimeda U; Murata T; Spee C; Ryan SJ; Hinton DR
Exp Eye Res; 1998 Jul; 67(1):45-52. PubMed ID: 9702177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
